Compare COFS & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | RGNX |
|---|---|---|
| Founded | 1898 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.9M | 528.6M |
| IPO Year | 1995 | 2015 |
| Metric | COFS | RGNX |
|---|---|---|
| Price | $34.16 | $9.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $34.00 | $28.75 |
| AVG Volume (30 Days) | 88.3K | ★ 2.3M |
| Earning Date | 04-24-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $227,624,000.00 | $10,393,000.00 |
| Revenue This Year | $22.13 | $51.21 |
| Revenue Next Year | $4.47 | $19.08 |
| P/E Ratio | $37.77 | ★ N/A |
| Revenue Growth | 63.64 | ★ 126.48 |
| 52 Week Low | $26.10 | $5.46 |
| 52 Week High | $34.90 | $16.19 |
| Indicator | COFS | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 57.54 | 41.15 |
| Support Level | $29.98 | $9.51 |
| Resistance Level | $34.88 | $10.16 |
| Average True Range (ATR) | 1.31 | 0.93 |
| MACD | -0.01 | -0.46 |
| Stochastic Oscillator | 88.15 | 16.60 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.